Shinichi Kako, Shun-Ichi Kimura, Hidenori Wada, Yusuke Komiya, Hideki Nakasone, Masatoshi Sakurai, Jun Kato, Masatsugu Tanaka, Eriko Fujii, Takayoshi Tachibana, Wataru Yamamoto, Maki Hagihara, Reiko Watanabe, Akira Yokota, Hirofumi Nakano, Takehiko Mori, Chiaki Nakaseko, Heiwa Kanamori, Shinichiro Okamoto, Yoshinobu Kanda
The optimal bridge strategy at the decision for allogeneic hematopoietic stem cell transplantation (HSCT) in patients with myelodysplastic syndrome (MDS) is unclear. We performed a prospective observational study in which 110 patients with MDS who were decided to undergo HSCT were enrolled. Among these 110 patients, 77 patients were enrolled in this study within 1 month from the decision for HSCT. Among these 77 patients, 13 patients had a human leukocyte antigen (HLA)-matched sibling, 54 patients started an unrelated donor search, and the other 10 patients directly selected cord blood (CB) at the decision for HSCT, and 13 (100%), 38 (70...
August 7, 2023: Leukemia Research